News

Advanced Search

Four Berger Montague Attorneys Honored at the American Antitrust Institute’s 2019 Antitrust Enforcement Awards

DATE: October 10, 2019
PRACTICE AREAS: Antitrust

Berger Montague is pleased to announce that David Sorensen, Daniel Simons, and Nick Urban have won the American Antitrust Institute’s 2019 Outstanding Antitrust Litigation Achievement in Private Practice Award for their work on King Drug Co. of Florence, Inc. v. Cephalon, Inc. (Provigil). In addition, AAI honored Josh Ripley for Outstanding Antitrust Litigation Achievement by a Young Lawyer for his work on In re Dental Supplies Antitrust Litigation.

The honorees will be featured at a gala awards dinner on November 12, 2019, following AAI’s Annual Private Antitrust Enforcement Conference.

AAI is an independent, nonprofit organization devoted to promoting competition that protects consumers, businesses, and society. It serves the public through research, education, and advocacy on the benefits of competition and the use of antitrust enforcement as a vital component of national and international competition policy.

Mr. Sorensen is a Managing Shareholder and Co-Chair of the Firm’s Antitrust department. He has played a leading role in numerous antitrust cases representing direct purchasers of prescription drugs. Many of these cases have alleged that pharmaceutical manufacturers have wrongfully kept less expensive generic drugs off the market, in violation of the antitrust laws.

Mr. Simons is Senior Counsel in the Antitrust and Consumer Protection groups. He concentrates a significant percentage of his practice on complex antitrust litigation, with a focus on anticompetitive arrangements in the pharmaceutical industry. Mr. Simons has been at the forefront of the efforts to curb “pay-for-delay” agreements, whereby brand companies compensate generic rivals to forestall the entry of lower priced generic equivalents.

Mr. Urban is an Associate in the Antitrust practice group. He focuses on antitrust class actions alleging that pharmaceutical manufacturers wrongfully kept less expensive generic drugs off the market, in violation of the antitrust laws. Mr. Urban has also devoted significant time to antitrust cases brought against the banking industry.

Mr. Ripley is an Associate in the Antitrust, Insurance Fraud, and Environment & Public Health practice groups. He graduated from Harvard Law School in 2015. While in law school, Mr. Ripley participated in various clinical organizations, including the Tenant Advocacy Project, the Employment Law Clinic, and the Predatory Lending and Consumer Protection Clinic.

Request A Free Consultation